Ameriprise’s Immatics IMTX Stock Holding History

Ameriprise’s Portfolio IMTX Stock Details IMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-332,243	Closed	-$3.85M	–	3933
2023 Q3	$3.85M	Buy	+332,243	New	+$3.97M	﹤0.01%	2477

Other funds holding IMTX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Ameriprise's IMTX Position: Q4 2023 in Review

Ameriprise sold out of Immatics (IMTX) in Q4 2023, closing a stake of 332,243 shares — an estimated $3.85M sold.

Ameriprise first reported a position in IMTX in Q3 2023 and held it in 1 quarter. The position peaked at $3.85M in Q3 2023. 76 funds tracked by Wall St. Rank hold IMTX as of Q4 2023.

Ameriprise reported no remaining Immatics position as of Q4 2023 after selling out during the quarter.
Ameriprise sold 332,243 Immatics shares in Q4 2023, an estimated $3.85M.
Ameriprise first reported a position in Immatics in Q3 2023 and held it in 1 quarter.
Ameriprise's Immatics position peaked at $3.85M in Q3 2023.
76 funds tracked by Wall St. Rank held Immatics as of Q4 2023.

Based on Ameriprise's 13F filing for Q4 2023, filed 14 Feb 2024.